Abstract
Pharmaceuticals such as antidepressants are designed to be bioactive at low concentrations. According to their mode of action, they can also influence non-target organisms due to the phylogenetic conservation of molecular targets. In addition to the pollution by environmental chemicals, the topic of microplastics (MP) in the aquatic environment came into the focus of scientific and public interest. The aim of the present study was to investigate the influence of the antidepressant amitriptyline in the presence and absence of irregularly shaped polystyrene MP as well as the effects of MP alone on juvenile brown trout (Salmo trutta f. fario). Fish were exposed to different concentrations of amitriptyline (nominal concentrations between 1 and 1000 µg/L) and two concentrations of MP (104 and 105 particles/L; <50 µm) for three weeks. Tissue cortisol concentration, oxidative stress, and the activity of two carboxylesterases and of acetylcholinesterase were assessed. Furthermore, the swimming behavior was analyzed in situations with different stress levels. Exposure to amitriptyline altered the behavior and increased the activity of acetylcholinesterase. Moreover, nominal amitriptyline concentrations above 300 µg/L caused severe acute adverse effects in fish. MP alone did not affect any of the investigated endpoints. Co-exposure caused largely similar effects such as the exposure to solely amitriptyline. However, the effect of amitriptyline on the swimming behavior during the experiment was alleviated by the higher MP concentration.
Funder
the German Ministry of Education and Research
Subject
Chemical Health and Safety,Health, Toxicology and Mutagenesis,Toxicology
Reference113 articles.
1. Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study;Liu;J. Psychiatr. Res.,2020
2. OECD (2019). Health at a Glance 2019: OECD Indicators, OECD Publishing.
3. Tricyclic antidepressants and monoamine oxidase Inhibitors: Are they too old for a new look?;Macaluso;Antidepressants: From Biogenic Amines to Newe Mechanisms of Action,2019
4. Schwabe, U., Paffrath, D., Ludwig, W.-D., and Klauber, J. (2019). Arzneiverordnungs-Report 2019—Aktuelle Daten, Kosten, Trends und Kommentare, Springer.
5. The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man;Drug Metab. Rev.,2004
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献